HiFiBiO Therapeutics
PrivateLast Round
Grant
Apr 16, 2024
Total Funding Raised
$179.5M
Company Overview
HiFiBiO Therapeutics is a biotechnology company that develops a single-cell analytics platform aimed at harnessing the human immune system to fight cancer and autoimmune disorders through innovative biotherapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HiFiBiO Therapeutics Comparables
Compare HiFiBiO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioInvent International | 78% | |
| Abcuro | 74% | |
| Aureka Biotechnologies | 74% |
HiFiBiO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2024 | ||||
| Series D | Jun 14, 2021 | ||||
| Series C | Aug 28, 2019 | ||||
| Series B | May 16, 2018 | ||||
| Series A | Jan 27, 2017 |
Key People
Founding team and executive leadership
HiFiBiO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series B, Series C |
| Legend Star | Series D |
| IDG Capital | Series D, Series C |
| Nest.Bio | Series B, Series A |
| Mirae Asset | Series D |
| B Capital Group | Series D |
| LYFE Capital | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2025
Attending the 2025 Annual Meeting of the European Society for Medical Oncology (ESMO).
- Jun 14, 2021
$75M round led by Mirae Asset Financial Services.
HiFiBiO Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HiFiBiO Therapeutics's valuation, stock price, and market status.
Is HiFiBiO a public or private company?
HiFiBiO is a private company.
What is the current stock price of HiFiBiO?
HiFiBiO is a private company with no public stock price. No recent secondary market data is available.
How much is HiFiBiO worth (valuation)?
Valuation information for HiFiBiO is not publicly available.
Can I buy HiFiBiO stock?
HiFiBiO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HiFiBiO's last funding round?
HiFiBiO's most recent funding round was Series D on June 14, 2021.
Who are the main investors in HiFiBiO?
Key investors in HiFiBiO include IDG Capital, LYFE Capital, Mirae Asset Financial Services, HongShan.
Will HiFiBiO IPO soon?
No public IPO plans have been announced for HiFiBiO.
How can I track HiFiBiO secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HiFiBiO's secondary market activity and sign up for updates.